The BioFlash® Biological Identifier is a bio-aerosol collection and identification system. The BioFlash® Biological Identifier is powered by CANARY® technology (a cell-based biosensor) and is combined with proprietary aerosol-collection techniques to provide rapid, sensitive and specific identification of biological-threat agents including viruses, toxins and bacteria.
BioFlash® Biological Identifier is capable of detecting airborne COVID-19 following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) using live SARS-CoV-2 virus in a Biosafety Level 3 containment area. The SARS-CoV-2 CANARY biosensor used in the BioFlash device demonstrated that it can quickly detect and identify the presence of low levels of aerosolized COVID-19.
Read our white paper to find out.
USAMRIID verification & results
The table below shows the accuracy of detection and identification by BioFlash of COVID-19 in the air at different concentrations in testing performed by USAMRIID. In six out of six aerosol tests, the BioFlash detected down to an estimated 6000 infectious particles of COVID-19. This compares to 1,000,000 environmental particles released from a human sneeze; 100,000 per cough; up to 10,000 emitted during one minute of talking; and 1,000 per minute of breathing.
USAMRIID Evaluation of BioFlash to Detect Aerosol SARS CoV-2
| Target PFU* | Number of Aerosol Tests |
Number of Positive Results |
% Positive |
|---|---|---|---|
| 2,000 | 6 | 0 | 0 |
| 4,000 | 6 | 3 | 50 |
| 6,000 | 6 | 6 | 100 |
| 8,000 | 6 | 6 | 100 |
| 10,000 | 6 | 6 | 100 |
| 20,000 | 6 | 6 | 100 |
| 40,000 | 4 | 4 | 100 |
| 60,000 | 4 | 4 | 100 |
| 100,000 | 2 | 2 | 100 |
| 1,000,000 | 2 | 2 | 100 |
Applications:
Hospitals
Government institutions
Corporate buildings
Athletic centres